{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T23:17:27Z","timestamp":1793229447918,"version":"4.5.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,11,25]],"date-time":"2020-11-25T00:00:00Z","timestamp":1606262400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,11,25]],"date-time":"2020-11-25T00:00:00Z","timestamp":1606262400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pulm Med"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Oxidative stress plays an important role in acute lung injury, which is associated with the development and progression of acute respiratory failure. Here, we investigated whether the degree of oxidative stress as indicated by serum heme oxygenase-1 (HO-1) is clinically useful for predicting prognosis among the patients with acute respiratory distress syndrome (ARDS) and acute exacerbation of interstitial lung disease (AE-ILD).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Serum HO-1 levels of newly diagnosed or untreated ARDS and AE-ILD patients were measured at diagnosis. Relationships between serum HO-1 and other clinical parameters and 1 and 3-month mortality were evaluated.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Fifty-five patients including 22 of ARDS and 33 of AE-ILD were assessed. Serum HO-1 level at diagnosis was significantly higher in ARDS patients than AE-ILD patients (87.8\u2009\u00b1\u200960.0\u2009ng\/mL vs. 52.5\u2009\u00b1\u200936.3\u2009ng\/mL,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u2009\u00a00.001). Serum HO-1 correlated with serum total bilirubin (R\u2009=\u20090.454, P\u2009&lt;\u2009\u00a00.001) and serum LDH (R\u2009=\u20090.500, P\u2009&lt;\u2009\u00a00.001). In both patients with ARDS and AE-ILDs, serum HO-1 level tended to decrease from diagnosis to 2\u2009weeks after diagnosis, however, did not normalized. Composite parameters including serum HO-1, age, sex, and partial pressure of oxygen in arterial blood\/fraction of inspired oxygen (P\/F) ratio for prediction of 3-month mortality showed a higher AUC (ARDS: 0.925, AE-ILDs: 0.892) than did AUCs of a single predictor or combination of two or three predictors.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Oxidative stress assessed by serum HO-1 is persistently high among enrolled patients for 2\u2009weeks after diagnosis. Also, serum HO-1 levels at the diagnosis combined with age, sex, and P\/F ratio could be clinically useful for predicting 3-month mortality in both ARDS and AE-ILD patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12890-020-01341-1","type":"journal-article","created":{"date-parts":[[2020,11,25]],"date-time":"2020-11-25T07:05:53Z","timestamp":1606287953000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Serum heme oxygenase-1 measurement is useful for evaluating disease activity and outcomes in patients with acute respiratory distress syndrome and acute exacerbation of interstitial lung disease"],"prefix":"10.1186","volume":"20","author":[{"given":"Ryo","family":"Nagasawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Hara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kota","family":"Murohashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayako","family":"Aoki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuaki","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeto","family":"Takagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoru","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiko","family":"Kawana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Kaneko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,11,25]]},"reference":[{"key":"1341_CR1","doi-asserted-by":"publisher","first-page":"R154","DOI":"10.1186\/cc5086","volume":"10","author":"VD Mayr","year":"2006","unstructured":"Mayr VD, D\u00fcnser MW, Greil V, Jochberger S, Luckner G, Ulmer H, Friesenecker BE, Takala J, Hasibeder WR. Causes of death and determinants of outcome in critically ill patients. Crit Care. 2006;10:R154.","journal-title":"Crit Care"},{"key":"1341_CR2","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1183\/09031936.00159709","volume":"37","author":"JW Song","year":"2011","unstructured":"Song JW, Hong SB, Lim CM, Koh Y, Kim DS. Acute exacerbation of idiopathic pulmonary fibrosis: incidence, risk factors and outcome. Eur Respir J. 2011;37:356\u201363.","journal-title":"Eur Respir J"},{"key":"1341_CR3","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1513\/AnnalsATS.201609-728PS","volume":"14","author":"P Cardinal-Fern\u00e1ndez","year":"2017","unstructured":"Cardinal-Fern\u00e1ndez P, Lorente JA, Ball\u00e9n-Barrag\u00e1n A, Matute-Bello G. Acute respiratory distress syndrome and diffuse alveolar damage. New insights on a complex relationship. Ann Am Thorac Soc. 2017;14:844\u201350.","journal-title":"Ann Am Thorac Soc"},{"key":"1341_CR4","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1097\/01.pas.0000213341.70852.9d","volume":"31","author":"A Churg","year":"2007","unstructured":"Churg A, M\u00fcller NL, Silva CI, Wright JL. Acute exacerbation (acute lung injury of unknown cause) in UIP and other forms of fibrotic interstitial pneumonias. Am J Surg Pathol. 2007;31:277\u201384.","journal-title":"Am J Surg Pathol"},{"key":"1341_CR5","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1164\/rccm.2009-040GL","volume":"183","author":"G Raghu","year":"2011","unstructured":"Raghu G, Collard HR, Egan JJ, Martinez FJ, Behr J, Brown KK, Colby TV, Cordier JF, Flaherty KR, Lasky JA, Lynch DA, Ryu JH, Swigris JJ, Wells AU, Ancochea J, Bouros D, Carvalho C, Costabel U, Ebina M, Hansell DM, Johkoh T, Kim DS, King TE Jr, Kondoh Y, Myers J, M\u00fcller NL, Nicholson AG, Richeldi L, Selman M, Dudden RF, Griss BS, Protzko SL, Sch\u00fcnemann HJ. ATS\/ERS\/JRS\/ALAT Committee on Idiopathic Pulmonary Fibrosis. An official ATS\/ERS\/JRS\/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med. 2011;183:788\u2013824.","journal-title":"Am J Respir Crit Care Med"},{"key":"1341_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12950-018-0202-y","volume":"16","author":"S Spadaro","year":"2019","unstructured":"Spadaro S, Park M, Turrini C, Tunstall T, Thwaites R, Mauri T, Ragazzi R, Ruggeri P, Hansel TT, Caramori G, Volta CA. Biomarkers for acute respiratory distress syndrome and prospects for personalised medicine. J Inflamm (Lond). 2019;16:1.","journal-title":"J Inflamm (Lond)"},{"key":"1341_CR7","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1080\/14728222.2018.1541318","volume":"22","author":"A Hosseinzadeh","year":"2018","unstructured":"Hosseinzadeh A, Javad-Moosavi SA, Reiter RJ, Yarahmadi R, Ghaznavi H, Mehrzadi S. Oxidative\/nitrosative stress, autophagy and apoptosis as therapeutic targets of melatonin in idiopathic pulmonary fibrosis. Expert Opin Ther Targets. 2018;22:1049\u201361.","journal-title":"Expert Opin Ther Targets"},{"key":"1341_CR8","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1164\/rccm.200501-017PP","volume":"172","author":"VL Kinnula","year":"2005","unstructured":"Kinnula VL, Fattman CL, Tan RJ, Oury TD. Oxidative stress in pulmonary fibrosis: a possible role for redox modulatory therapy. Am J Respir Crit Care Med. 2005;172:417\u201322.","journal-title":"Am J Respir Crit Care Med"},{"key":"1341_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10753-019-01059-1","volume":"43","author":"P Cameli","year":"2020","unstructured":"Cameli P, Carleo A, Bergantini L, Landi C, Prasse A, Bargagli E. Oxidant\/antioxidant disequilibrium in idiopathic pulmonary fibrosis pathogenesis. Inflammation. 2020;43:1\u20137.","journal-title":"Inflammation."},{"key":"1341_CR10","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.niox.2019.05.001","volume":"89","author":"P Cameli","year":"2019","unstructured":"Cameli P, Bergantini L, Salvini M, et al. Alveolar concentration of nitric oxide as a prognostic biomarker in idiopathic pulmonary fibrosis. Nitric Oxide. 2019;89:41\u20135.","journal-title":"Nitric Oxide"},{"key":"1341_CR11","doi-asserted-by":"publisher","first-page":"L369","DOI":"10.1152\/ajplung.00456.2018","volume":"316","author":"LES de Groot","year":"2019","unstructured":"de Groot LES, van der Veen TA, Martinez FO, Hamann J, Lutter R, Melgert BN. Oxidative stress and macrophages: driving forces behind exacerbations of asthma and chronic obstructive pulmonary disease? Am J Physiol Lung Cell Mol Physiol. 2019;316:L369\u201384.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"1341_CR12","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1034\/j.1399-3003.1999.13a31.x","volume":"13","author":"AG Lenz","year":"1999","unstructured":"Lenz AG, Jorens PG, Meyer B, De Backer W, Van Overveld F, Bossaert L, Maier KL. Oxidatively modified proteins in bronchoalveolar lavage fluid of patients with ARDS and patients at-risk for ARDS. Eur Respir J. 1999;13:169\u201374.","journal-title":"Eur Respir J"},{"key":"1341_CR13","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1016\/j.rmed.2009.04.014","volume":"103","author":"E Bargagli","year":"2009","unstructured":"Bargagli E, Olivieri C, Bennett D, Prasse A, Muller-Quernheim J, Rottoli P. Oxidative stress in the pathogenesis of diffuse lung diseases: a review. Respir Med. 2009;103:1245\u201356.","journal-title":"Respir Med"},{"key":"1341_CR14","doi-asserted-by":"publisher","first-page":"L642","DOI":"10.1152\/ajplung.00275.2017","volume":"314","author":"L Hecker","year":"2018","unstructured":"Hecker L. Mechanisms and consequences of oxidative stress in lung disease: therapeutic implications for an aging populace. Am J Physiol Lung Cell Mol Physiol. 2018;314:L642\u201353.","journal-title":"Am J Physiol Lung Cell Mol Physiol."},{"key":"1341_CR15","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1165\/rcmb.2006-0331TR","volume":"36","author":"LE Fredenburgh","year":"2007","unstructured":"Fredenburgh LE, Perrella MA, Mitsialis SA. The role of heme oxygenase-1 in pulmonary disease. Am J Respir Cell Mol Biol. 2007;36:158\u201365.","journal-title":"Am J Respir Cell Mol Biol"},{"key":"1341_CR16","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1016\/j.bbrc.2005.08.020","volume":"338","author":"G Kikuchi","year":"2005","unstructured":"Kikuchi G, Yoshida T, Noguchi M. Heme oxygenase and heme degradation. Biochem Biophys Res Commun. 2005;338:558\u201367.","journal-title":"Biochem Biophys Res Commun"},{"key":"1341_CR17","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1165\/rcmb.2007-0424OC","volume":"39","author":"M Suzuki","year":"2008","unstructured":"Suzuki M, Betsuyaku T, Ito Y, Nagai K, Nasuhara Y, Kaga K, Kondo S, Nishimura M. Down-regulated NF-E2-related factor 2 in pulmonary macrophages of aged smokers and patients with chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol. 2008;39:673\u201382.","journal-title":"Am J Respir Cell Mol Biol"},{"key":"1341_CR18","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1097\/01.CCM.0000124869.86399.F2","volume":"32","author":"S Mumby","year":"2004","unstructured":"Mumby S, Upton RL, Chen Y, Stanford SJ, Quinlan GJ, Nicholson AG, Gutteridge JM, Lamb NJ, Evans TW. Lung heme oxygenase-1 is elevated in acute respiratory distress syndrome. Crit Care Med. 2004;32:1130\u20135.","journal-title":"Crit Care Med"},{"key":"1341_CR19","doi-asserted-by":"publisher","first-page":"9627420","DOI":"10.1155\/2018\/9627420","volume":"2018","author":"Y Hara","year":"2018","unstructured":"Hara Y, Shinkai M, Taguri M, Nagai K, Hashimoto S, Kaneko T. ELISA development for serum hemeoxygenase-1 and its application to patients with acute respiratory distress syndrome. Can Respir J. 2018;2018:9627420.","journal-title":"Can Respir J"},{"key":"1341_CR20","doi-asserted-by":"publisher","first-page":"7260178","DOI":"10.1155\/2018\/7260178","volume":"2018","author":"K Murohashi","year":"2018","unstructured":"Murohashi K, Hara Y, Shinada K, Nagai K, Shinkai M, Kawana A, Kaneko T. Clinical significance of serum hemeoxygenase-1 as a new biomarker for the patients with interstitial pneumonia. Can Respir J. 2018;2018:7260178.","journal-title":"Can Respir J"},{"key":"1341_CR21","first-page":"2526","volume":"307","author":"ARDS Definition Task Force","year":"2012","unstructured":"Definition Task Force ARDS, Ranieri VM, Rubenfeld GD, Thompson BT, Ferguson ND, Caldwell E, Fan E, Camporota L, Slutsky AS. Acute respiratory distress syndrome: the Berlin Definition. JAMA. 2012;307:2526\u201333.","journal-title":"JAMA."},{"key":"1341_CR22","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1164\/rccm.201308-1483ST","volume":"188","author":"WD Travis","year":"2013","unstructured":"Travis WD, Costabel U, Hansell DM, King TE Jr, Lynch DA, Nicholson AG, Ryerson CJ, Ryu JH, Selman M, Wells AU, Behr J, Bouros D, Brown KK, Colby TV, Collard HR, Cordeiro CR, Cottin V, Crestani B, Drent M, Dudden RF, Egan J, Flaherty K, Hogaboam C, Inoue Y, Johkoh T, Kim DS, Kitaichi M, Loyd J, Martinez FJ, Myers J, Protzko S, Raghu G, Richeldi L, Sverzellati N, Swigris J, Valeyre D, ATS\/ERS Committee on Idiopathic Interstitial Pneumonias. An official American Thoracic Society\/European Respiratory Society statement: Update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med. 2013;188:733\u201348.","journal-title":"Am J Respir Crit Care Med"},{"key":"1341_CR23","doi-asserted-by":"publisher","first-page":"e3","DOI":"10.1164\/rccm.201506-1063ST","volume":"192","author":"G Raghu","year":"2015","unstructured":"Raghu G, Rochwerg B, Zhang Y, et al. American Thoracic Society; EuropeanRespiratory society; Japanese respiratory society; Latin American thoracic association. An official ATS\/ERS\/JRS\/ALAT clinical practice guideline: treatment of idiopathic pulmonary fibrosis. An update of the 2011 clinical practice guideline. Am J Respir Crit Care Med. 2015;192:e3\u201319.","journal-title":"Am J Respir Crit Care Med"},{"key":"1341_CR24","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.1378\/chest.07-0299","volume":"132","author":"R Hyzy","year":"2007","unstructured":"Hyzy R, Huang S, Myers J, Flaherty K, Martinez F. Acute exacerbation of idiopathic pulmonary fibrosis. Chest. 2007;132:1652\u20138.","journal-title":"Chest."},{"key":"1341_CR25","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1378\/chest.07-0323","volume":"132","author":"IN Park","year":"2007","unstructured":"Park IN, Kim DS, Shim TS, Lim CM, Lee SD, Koh Y, Kim WS, Kim WD, Jang SJ, Colby TV. Acute exacerbation of interstitial pneumonia other than idiopathic pulmonary fibrosis. Chest. 2007;132:214\u201320.","journal-title":"Chest."},{"key":"1341_CR26","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1097\/00003246-198510000-00009","volume":"13","author":"WA Knaus","year":"1985","unstructured":"Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med. 1985;13:818\u201329.","journal-title":"Crit Care Med"},{"key":"1341_CR27","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1164\/rccm.200508-1237OC","volume":"174","author":"T Sato","year":"2006","unstructured":"Sato T, Takeno M, Honma K, Yamauchi H, Saito Y, Sasaki T, Morikubo H, Nagashima Y, Takagi S, Yamanaka K, Kaneko T, Ishigatsubo Y. Heme oxygenase-1, a potential biomarker of chronic silicosis, attenuates silica-induced lung injury. Am J Respir Crit Care Med. 2006;174:906\u201314.","journal-title":"Am J Respir Crit Care Med"},{"key":"1341_CR28","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1186\/s12931-018-0852-6","volume":"19","author":"K Nakashima","year":"2018","unstructured":"Nakashima K, Sato T, Shigemori S, Shimosato T, Shinkai M, Kaneko T. Regulatory role of heme oxygenase-1 in silica-induced lung injury. Respir Res. 2018;19:144.","journal-title":"Respir Res"},{"key":"1341_CR29","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1053\/hupa.2001.28937","volume":"32","author":"E Lakari","year":"2001","unstructured":"Lakari E, Pylk\u00e4s P, Pietarinen-Runtti P, P\u00e4\u00e4kk\u00f6 P, Soini Y, Kinnula VL. Expression and regulation of hemeoxygenase 1 in healthy human lung and interstitial lung disorders. Hum Pathol. 2001;32:1257\u201363.","journal-title":"Hum Pathol"},{"key":"1341_CR30","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1186\/s13054-015-0949-y","volume":"19","author":"KC Kao","year":"2015","unstructured":"Kao KC, Hu HC, Chang CH, Hung CY, Chiu LC, Li SH, Lin SW, Chuang LP, Wang CW, Li LF, Chen NH, Yang CT, Huang CC, Tsai YH. Diffuse alveolar damage associated mortality in selected acute respiratory distress syndrome patients with open lung biopsy. Crit Care. 2015;19:228.","journal-title":"Crit Care"},{"key":"1341_CR31","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2013-002971","volume":"3","author":"Y Usui","year":"2013","unstructured":"Usui Y, Kaga A, Sakai F, Shiono A, Komiyama K, Hagiwara K, Kanazawa M. A cohort study of mortality predictors in patients with acute exacerbation of chronic fibrosing interstitial pneumonia. BMJ Open. 2013;3:e002971.","journal-title":"BMJ Open"},{"key":"1341_CR32","doi-asserted-by":"publisher","first-page":"161","DOI":"10.3389\/fcimb.2018.00161","volume":"8","author":"MLM Pereira","year":"2018","unstructured":"Pereira MLM, Marinho CRF, Epiphanio S. Could Heme Oxygenase-1 be a new target for therapeutic intervention in malaria-associated acute lung injury\/acute respiratory distress syndrome? Front Cell Infect Microbiol. 2018;8:161.","journal-title":"Front Cell Infect Microbiol"},{"key":"1341_CR33","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1001\/jama.1968.03140260033015","volume":"204","author":"RA DeRemee","year":"1968","unstructured":"DeRemee RA. Serum lactic dehydrogenase activity and diffuse interstitial pneumonitis. JAMA. 1968;204:1193\u20135.","journal-title":"JAMA."},{"key":"1341_CR34","doi-asserted-by":"publisher","first-page":"621","DOI":"10.2169\/internalmedicine.56.7418","volume":"56","author":"Y Hara","year":"2017","unstructured":"Hara Y, Shinkai M, Kanoh S, Fujikura Y, Rubin BK, Kawana A, Kaneko T. Arterial carboxyhemoglobin measurement is useful for evaluating pulmonary inflammation in subjects with interstitial lung disease. Intern Med. 2017;56:621\u20136.","journal-title":"Intern Med"},{"key":"1341_CR35","doi-asserted-by":"publisher","first-page":"2387","DOI":"10.1378\/chest.128.4.2387","volume":"128","author":"S Kanoh","year":"2005","unstructured":"Kanoh S, Kobayashi H, Motoyoshi K. Exhaled ethane: an in vivo biomarker of lipid peroxidation in interstitial lung diseases. Chest. 2005;128:2387\u201392.","journal-title":"Chest."},{"key":"1341_CR36","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1165\/rcmb.2006-0340TR","volume":"36","author":"J Alam","year":"2007","unstructured":"Alam J, Cook JL. How many transcription factors does it take to turn on the heme oxygenase-1 gene? Am J Respir Cell Mol Biol. 2007;36:166\u201374.","journal-title":"Am J Respir Cell Mol Biol"},{"key":"1341_CR37","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1056\/NEJMra050541","volume":"353","author":"T Rhen","year":"2005","unstructured":"Rhen T, Cidlowski JA. Antiinflammatory action of glucocorticoids--new mechanisms for old drugs. N Engl J Med. 2005;353:1711\u201323.","journal-title":"N Engl J Med"},{"key":"1341_CR38","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1056\/NEJMoa051693","volume":"354","author":"KP Steinberg","year":"2006","unstructured":"Steinberg KP, Hudson LD, Goodman RB, Hough CL, Lanken PN, Hyzy R, Thompson BT, Ancukiewicz M, National Heart, Lung, and Blood Institute acute respiratory distress syndrome (ARDS) clinical trials network. Efficacy and safety of corticosteroids for persistent acute respiratory distress syndrome. N Engl J Med. 2006;354:1671\u201384.","journal-title":"N Engl J Med"},{"key":"1341_CR39","first-page":"499","volume":"7","author":"MM Juarez","year":"2015","unstructured":"Juarez MM, Chan AL, Norris AG, Morrissey BM, Albertson TE. Acute exacerbation of idiopathic pulmonary fibrosis-a review of current and novel pharmacotherapies. J Thorac Dis. 2015;7:499\u2013519.","journal-title":"J Thorac Dis."},{"key":"1341_CR40","first-page":"20191698","volume":"286","author":"AD Majer","year":"2019","unstructured":"Majer AD, Fasanello VJ, Tindle K, Frenz BJ, Ziur AD, Fischer CP, Fletcher KL, Seecof OM, Gronsky S, Vassallo BG, Reed WL, Paitz RT, Stier A, Haussmann MF. Is there an oxidative cost of acute stress? Characterization, implication of glucocorticoids and modulation by prior stress experience. Proc Biol Sci. 2019;286:20191698.","journal-title":"Proc Biol Sci"},{"key":"1341_CR41","doi-asserted-by":"publisher","first-page":"44326","DOI":"10.1074\/jbc.M111.283481","volume":"286","author":"M Almeida","year":"2011","unstructured":"Almeida M, Han L, Ambrogini E, Weinstein RS, Manolagas SC. Glucocorticoids and tumor necrosis factor \u03b1 increase oxidative stress and suppress Wnt protein signaling in osteoblasts. J Biol Chem. 2011;286:44326\u201335.","journal-title":"J Biol Chem"},{"key":"1341_CR42","doi-asserted-by":"publisher","first-page":"e13087","DOI":"10.1097\/MD.0000000000013087","volume":"97","author":"Q Zhang","year":"2018","unstructured":"Zhang Q, Ju Y, Ma Y, Wang T. N-acetylcysteine improves oxidative stress and inflammatory response in patients with community acquired pneumonia: A randomized controlled trial. Medicine. (Baltimore). 2018;97:e13087.","journal-title":"Medicine. (Baltimore)"},{"key":"1341_CR43","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/s00408-013-9530-0","volume":"192","author":"T Kishaba","year":"2014","unstructured":"Kishaba T, Tamaki H, Shimaoka Y, Fukuyama H, Yamashiro S. Staging of acute exacerbation in patients with idiopathic pulmonary fibrosis. Lung. 2014;192:141\u20139.","journal-title":"Lung."},{"key":"1341_CR44","doi-asserted-by":"publisher","first-page":"2448","DOI":"10.21037\/jtd.2019.05.46","volume":"11","author":"K Murohashi","year":"2019","unstructured":"Murohashi K, Hara Y, Saigusa Y, Kobayashi N, Sato T, Yamamoto M, Kudo M, Kaneko T. Clinical significance of Charlson comorbidity index as a prognostic parameter for patients with acute or subacute idiopathic interstitial pneumonias and acute exacerbation of collagen vascular diseases-related interstitial pneumonia. J Thorac Dis. 2019;11:2448\u201357.","journal-title":"J Thorac Dis"}],"container-title":["BMC Pulmonary Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-020-01341-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12890-020-01341-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-020-01341-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,25]],"date-time":"2020-11-25T07:10:34Z","timestamp":1606288234000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpulmmed.biomedcentral.com\/articles\/10.1186\/s12890-020-01341-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,25]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1341"],"URL":"https:\/\/doi.org\/10.1186\/s12890-020-01341-1","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-39746\/v2","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-39746\/v1","asserted-by":"object"}]},"ISSN":["1471-2466"],"issn-type":[{"value":"1471-2466","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,25]]},"assertion":[{"value":"2 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 November 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All aspects of this research were approved by the Institutional Review Board of Yokohama City University Graduate School of Medicine (approval numbers B170900025 and A181100007). The severely ill condition or deep sedation of ARDS and AE-ILD patients precluded us from obtaining informed consent from the patients themselves. Therefore, written informed consent was obtained from the patients\u2019 relatives or their legal guardians. Control subjects provided written informed consent prior to participation in this study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written consent for publication from the patients or their next of kin was obtained.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"310"}}